Large addressable market Cera serves a population of 30 million across the UK and Germany with technology-enabled home care, implying a broad potential customer base for expanded services, partnerships with public health systems, insurers, and employers seeking in-home care solutions.

Cost advantage Operational model emphasizes higher quality care at a fraction of traditional costs, suggesting opportunities to position Cera as a cost-saving partner for NHS, insurers, and governments, particularly for episodic hospital avoidance programs.

Data and AI leverage Extensive home healthcare data powering AI products that reduce hospitalisations by up to 70% creates sales opportunities around analytics services, digital health tools, risk stratification, and predictive care offerings for health systems and payers.

Scale and credibility 60,000 patient appointments per day and recognition as a top HealthTech company with multiple awards enhances credibility for enterprise contracts and international expansion, especially with public sector buyers seeking proven partners.

Expansion-ready partnerships Existing government, insurer and NHS collaborations signal readiness for broader contracts, including managed care programs, home-first care pilots, and integration with hospital networks desiring to shift suitable care from inpatient settings.